Fenbendazole and Cancer Remission Study

This is a huge study. This is three, three stage four

cancer patients, melanoma,

uh, breast cancer and prostate cancer.

Uh, these three advanced cancer patients

experienced

remission, in two cases complete remission,

and in one case near

remission, um, for an extended period of time,

years after

initiating this fenbendazole protocol.

Um, and none of them received chemo either,

right?

So this was with-- it was in combination, a few were with a surgery.

Um, some did receive a, you know, a brief dose of radiation.

But in general, this fenbendazole was linked

to extraordinarily, you know,

ex-accelerated tumor reductions, um, in a

pretty short period of time with extended

survival outcomes, with, um, no evidence of

disease. And so this is absolutely huge, right?

And this, this corroborates, um, the preclinical

data, right? So when they were testing this in animals,

they found so many

different anti-cancer mechanisms.

And so now we see in humans for the, basically the first

time that this does appear to have real anti-tumor

effects clinically. And it is an anti-parasitic like

ivermectin. And so we see, we see the same things as well with

ivermectin.

Usually, sometimes these doctors pair ivermectin

with

fenbendazole. And so this is very promising.

What we do really need now, though, before we can make claims that it's curing

cancer, we need large scale clinical trials

immediately. As this cancer epidemic increases, it's

time for proper study of these extremely safe and

cheap

compounds.